Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

Mintz Member Tara Dwyer was quoted in a Bloomberg Government article on the passage of the bipartisan infrastructure package and reconciliation bill, which would be paid for in part by delaying a controversial rebate rule – a rule which pharmacy benefit managers and insurers are in stiff opposition to.

Mintz Member Anne Levin-Nussbaum authored an article published by Tax Notes explaining how foreign investors in U.S. renewables projects might determine how much debt to use when capitalizing a U.S. blocker corporation.

Massachusetts Lawyers Weekly reported on a recent decision by the 1st U.S. Circuit Court of Appeals in Karth v. Keryx Biopharmaceuticals Inc., which said a Keryx Biopharmaceuticals Inc. investor cannot revive his lawsuit alleging the Boston-based pharmaceutical company hid supply chain issues. Mintz Member Laurence A. Schoen, who represented the biopharma company, discussed how the decision closes the door on ‘fraud by hindsight’ claims.

Mintz Member Jennifer B. Rubin was quoted in an article published by EHS Today to discuss the Centers for Disease Control and Prevention (CDC)’s new mask mandate, offering practical guidance regarding the changes, if any, employers might consider in response to the latest CDC guidance.

Law360 highlighted the arrival of Anne Levin-Nussbaum as a Member in Mintz’s Tax and Energy & Sustainability Practices in New York. The article discussed her 25 years of experience advising clients on a wide range of US federal income tax matters, with a particular focus in the renewable energy finance area. The piece also included commentary from Managing Member Bob Bodian on what her addition brings to the team.

Mintz Member Dianne Bourque was quoted in an article published by Bloomberg Law about how the Centers for Medicare & Medicaid Services (CMS) has proposed the use of an algorithm in hospitals that guesses people’s race to improve health inequity gaps. The artificial intelligence is intended to serve as a stand-in until CMS can get patients to self-identify.